₹ 145000 / 1000 shares
Issue Date
22 Aug - 26 Aug'25
Investment/lot
₹ 145000
Price Range
137 - 145
Lot Size
1000
IPO Size
₹ 65.66 - ₹ 69.5 Cr
Start date
22/08/2025
End date
26/08/2025
Allotment of bids
28/08/2025
Refund Initiation
29/08/2025
Listing on exchange
01/09/2025
The IPO of Anondita Medicare Ltd comprises a fresh issue of up to 47,93,000 equity shares of face value of ₹10 each. There is no offer for sale in this 100% book-built issue. The price band is ₹137 to ₹145 per share and the lot size is 1000 shares.
The IPO opens on August 22, 2025 and closes on August 26, 2025. The listing date is on or before September 1, 2025 and the allotment date is on or before August 28, 2025. The credit of shares to the Demat account will take place on August 29, 2025, while the initiation of refund will take place on August 29, 2025.
Anondita Medicare Ltd is a manufacturer of male condoms with a variety of flavours, with its flagship product marketed and sold under the brand “COBRA”. It has an installed production capacity of nearly 562 million condoms per annum.
The company plans to utilise the proceeds for:
Investor | Shares Offered |
---|---|
Market Maker | 5.63% of the issue size |
QIBs | Not more than 50% of the net offer |
Non-institutional Investor | Not less than 15% of the offer |
Retail Individual Investors | Not less than 35% of the offer |
The Indian condom market has demonstrated exceptional growth through 2024, reaching a valuation of approximately USD 245 million, representing year-on-year growth of 8.4%. Market projections indicate continued robust expansion, with expectations of reaching USD 410 million by 2030, reflecting a compound annual growth rate (CAGR) of 8.9% over the forecast period.
This growth trajectory significantly outpaces global market averages, driven by India's unique demographic advantages, evolving social attitudes, and supportive government policies. The market's expansion reflects successful awareness campaigns, improved distribution networks, and increasing acceptance of contraceptive products across diverse population segments.
The Indian condom market represents approximately 2.8% of the global condom market by value but accounts for nearly 15% by volume, reflecting the price-sensitive nature of the domestic market and the emphasis on accessible contraception for public health objectives.
Anondita Medicare Ltd is a manufacturer of male condoms with a variety of flavours, with its flagship product marketed and sold under the brand “COBRA”. It has an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated June 04, 2025. Further, to follow sustainable production practices, the company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant.
The strengths of Anondita Medicare Ltd and the basis of its issue price are:
Company Name | PAT (in ₹ crores) | Return on Net Worth (in %) | NAV (in ₹ per share) |
---|---|---|---|
Anondita Medicare Ltd | 2.16 | 12.45 | 20.57 |
Cupid Ltd | 8.25 | NA | NA |
Manufacturer of male condoms under the brand ‘Cobra’, Anondita Medicare Ltd’s condoms are available under different flavours such as strawberry, mint, chocolate, butterscotch, coffee, bubble gum, etc. Encouraged by demand and overwhelming responses from consumers it has also started the production of female condoms.
The company’s revenue PAT increased from ₹ (0.0038) crores in FY 24 to ₹10.7998 crores in FY 25. Its EBITDA increased from ₹ (0.0038) crores in FY 24 to ₹17.8846 crores in FY 25. Quality assurance and control coupled with cordial relations with customers has helped the company grow with time.
Incorporated in March 2024, Anondita Medicare Ltd boasts a state-of-the-art plant located in Noida, Uttar Pradesh. Its manufacturing capability is supported by 11 existing manufacturing lines at the moment.
Parameter | FY 24 | FY 23 | FY 22 |
---|---|---|---|
Total Revenue (in ₹ crores) | 46.55 | 36.13 | 23.25 |
Profit Before Tax (in ₹ crores) | 5.15 | 0.46 | 2.19 |
Profit After Tax (in ₹ crores) | 3.84 | 0.34 | 1.58 |
EPS in ₹ | NA | NA | NA |
Parameter | FY 24 | FY 23 | FY 22 |
---|---|---|---|
Profit Before Tax (in ₹ crores) | 5.15 | 0.46 | 2.19 |
Net Cash Provided / (used) by Operating Activities (in ₹ crores) | 7.75 | (9.16) | 4.03 |
Net Cash Provided / (used) by Investing Activities (in ₹ crores) | (3.74) | (0.58) | (1.00) |
Net Cash Provided / (used) by Financing Activities (in ₹ crores) | (3.99) | 9.90 | (3.16) |
Cash and Cash Equivalents at the End of Period (in ₹ crores) | 0.26 | 0.25 | 0.10 |
Via the Registrar’s Website
Check on the National Stock Exchange Website
The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Anondita Medicare Ltd. Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.
On the NSE IPO Bid Verification page, enter:
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
The minimum lot size is 1000 shares and the investment required is ₹145000.
The price band of Anondita Medicare IPO is ₹137 to ₹145.
You can read more about Anondita Medicare and its IPO from the company’s red herring prospectus (RHP) here.
The IPO of Anondita Medicare Ltd comprises a fresh issue of up to 47,93,000 equity shares
The exact dates of the IPO are yet to be announced.